These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2143703)

  • 41. Cell phenotype instability in preneoplastic foci of rat liver.
    Estadella MD; Pujol MJ; Domingo J
    Carcinogenesis; 1988 Apr; 9(4):563-6. PubMed ID: 2833365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction and promotion of gamma-glutamyltranspeptidase-positive foci in the rat liver by methylglyoxal.
    Martelli A; Ghia M; Mereto E; Marinari UM; Brambilla G
    Jpn J Cancer Res; 1988 Jun; 79(6):666-9. PubMed ID: 2900825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose-response studies on the effects of alpha-, beta-, and gamma-hexachlorocyclohexane on putative preneoplastic foci, monooxygenases, and growth in rat liver.
    Schröter C; Parzefall W; Schröter H; Schulte-Hermann R
    Cancer Res; 1987 Jan; 47(1):80-8. PubMed ID: 2431769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered liver acini induced in diabetic rats by portal vein islet isografts resemble preneoplastic hepatic foci in their enzymic pattern.
    Dombrowski F; Filsinger E; Bannasch P; Pfeifer U
    Am J Pathol; 1996 Apr; 148(4):1249-56. PubMed ID: 8644865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of the nature and the dose of the initiator on the development of premalignant and malignant lesions in rat hepatocarcinogenesis.
    Préat V; de Gerlache J; Lans M; Taper H; Roberfroid M
    Teratog Carcinog Mutagen; 1986; 6(3):165-72. PubMed ID: 2875529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Foci of altered liver cells induced by a single dose of diethylnitrosamine and partial hepatectomy: their contribution to hepatocarcinogenesis in the rat.
    Scherer E; Emmelot P
    Eur J Cancer (1965); 1975 Mar; 11(3):145-54. PubMed ID: 124252
    [No Abstract]   [Full Text] [Related]  

  • 47. Biochemical markers associated with the stages of promotion and progression during hepatocarcinogenesis in the rat.
    Pitot HC; Dragan Y; Sargent L; Xu YH
    Environ Health Perspect; 1991 Jun; 93():181-9. PubMed ID: 1723043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of altered liver cell foci and persistent nodule growth by vanadium during diethylnitrosamine-induced hepatocarcinogenesis in rats.
    Bishayee A; Chatterjee M
    Anticancer Res; 1995; 15(2):455-61. PubMed ID: 7763021
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of glucose-6-phosphate dehydrogenase on enhanced proliferation of pre-neoplastic and neoplastic cells in rat liver induced by N-nitrosomorpholine.
    Baba M; Yamamoto R; Iishi H; Tatsuta M; Wada A
    Int J Cancer; 1989 May; 43(5):892-5. PubMed ID: 2565888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Existence of a practical threshold dose for the hepatocarcinogen 3'-methyl-4-(dimethyl-amino) azobenzene in rat liver.
    Hino O; Kitagawa T
    Gan; 1981 Aug; 72(4):637-8. PubMed ID: 6458530
    [No Abstract]   [Full Text] [Related]  

  • 51. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver.
    Cattley RC; Popp JA
    Cancer Res; 1989 Jun; 49(12):3246-51. PubMed ID: 2566380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative stereologic study of the effects of varying the time between initiation and promotion on four histochemical markers in rat liver during hepatocarcinogenesis.
    Xu YH; Maronpot R; Pitot HC
    Carcinogenesis; 1990 Feb; 11(2):267-72. PubMed ID: 1967985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancing effect of malachite green on the development of hepatic pre-neoplastic lesions induced by N-nitrosodiethylamine in rats.
    Fernandes C; Lalitha VS; Rao KV
    Carcinogenesis; 1991 May; 12(5):839-45. PubMed ID: 1674233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor suppression effects of bilberry extracts and enzymatically modified isoquercitrin in early preneoplastic liver cell lesions induced by piperonyl butoxide promotion in a two-stage rat hepatocarcinogenesis model.
    Hara S; Morita R; Ogawa T; Segawa R; Takimoto N; Suzuki K; Hamadate N; Hayashi SM; Odachi A; Ogiwara I; Shibusawa S; Yoshida T; Shibutani M
    Exp Toxicol Pathol; 2014 Aug; 66(5-6):225-34. PubMed ID: 24680176
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition by pentachlorophenol of the initiating and promoting activities of 1'-hydroxysafrole for the formation of enzyme-altered foci and tumors in rat liver.
    Boberg EW; Liem A; Miller EC; Miller JA
    Carcinogenesis; 1987 Apr; 8(4):531-9. PubMed ID: 2881629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.
    Schulte-Hermann R; Timmermann-Trosiener I; Barthel G; Bursch W
    Cancer Res; 1990 Aug; 50(16):5127-35. PubMed ID: 2379175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multistage hepatocarcinogenesis in the rat: insights into risk estimation.
    Dragan YP; Pitot HC
    Prog Clin Biol Res; 1992; 374():261-79. PubMed ID: 1620707
    [No Abstract]   [Full Text] [Related]  

  • 58. Diethylnitrosamine initiation does not alter clofibric acid-induced hepatocarcinogenesis in the rat.
    Michel C; Desdouets C; Slaoui M; Isaacs KR; Roberts RA; Boitier E
    Toxicol Sci; 2007 Sep; 99(1):58-69. PubMed ID: 17602206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Facilitated expression of adaptive responses to phenobarbital in putative pre-stages of liver cancer.
    Schulte-Hermann R; Timmermann-Trosiener I; Schuppler J
    Carcinogenesis; 1986 Oct; 7(10):1651-5. PubMed ID: 2875809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modeling the number and size of hepatic focal lesions following exposure to 2,3,7,8-TCDD.
    Portier CJ; Sherman CD; Kohn M; Edler L; Kopp-Schneider A; Maronpot RM; Lucier G
    Toxicol Appl Pharmacol; 1996 May; 138(1):20-30. PubMed ID: 8658509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.